Corrigendum: Stem Cell Therapy in Dengue Virus-Infected BALB/C Mice Improves Hepatic Injury

Front Cell Dev Biol. 2022 Feb 1:9:800659. doi: 10.3389/fcell.2021.800659. eCollection 2021.

¹ Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Seri Kembangan, Malaysia.
² Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakakah, Saudi Arabia.
³ Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Seri Kembangan, Malaysia.
⁴ Bioinformatics and Computational Biology, Malaysia Genome Institute, National Institute of Biotechnology Malaysia (NIBM), Kajang, Malaysia.
⁵ Institute of Health, Kunming Medical University, Kunming, China.
⁶ Department of Medical Microbiology, School of Public Health, Fudan University, Shanghai, China.
⁷ First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, China.
⁸ Sultan Idris Education University, Tanjong Malim, Malaysia.
⁹ School of Bioscience, Faculty of Medicine, Bioscience and Nursing, MAHSA University, Jenjarom, Malaysia.
¹⁰ Department of Chemical and Materials Engineering, National Central University, Taoyuan City, Taiwan.
¹¹ R&D Center for Membrane Technology, Chung Yuan Christian University, Taoyuan City, Taiwan.
¹² Centre for Materials Engineering and Regenerative Medicine, Bharath Institute of Higher Education and Research, Chennai, India.

Abstract

[This corrects the article DOI: 10.3389/fcell.2021.637270.].

Keywords: DENV 2; dengue infection; hepatology; next-generation sequencing; stem cell therapy.